Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 Effective global drug development strategy for obtaining regulatory approval in Japan in the context of ethnicity-related drug response factors.

× No keyword cloud information.

13 in total

1. Population/regional differences in efficacy of 3 drug categories (antidiabetic, respiratory and psychotropic agents) among East Asians: A retrospective study based on multiregional clinical trials.

Authors: Kimie Sai; Akiomi Yoshida; Tadaaki Hanatani; Takuya Imatoh; Masahiro Takeuchi; Mamoru Narukawa; Hiroshi Watanabe; Yoshiaki Uyama; Yoshiro Saito
Journal: Br J Clin Pharmacol Date: 2019-03-28 Impact factor: 4.335

Review 2. The need for multicentre cardiovascular clinical trials in Asia.

Authors: Joey S W Kwong; Cheuk-Man Yu
Journal: Nat Rev Cardiol Date: 2013-04-16 Impact factor: 32.419

3. Differences in maximum tolerated doses and approval doses of molecularly targeted oncology drug between Japan and Western countries.

Authors: Hideki Maeda; Tatsuo Kurokawa
Journal: Invest New Drugs Date: 2014-03-11 Impact factor: 3.850

4. Application of Physiologically-Based Pharmacokinetic Modeling for the Prediction of Tofacitinib Exposure in Japanese.

Authors: Misaki Suzuki; Susanna Tse; Midori Hirai; Yoichi Kurebayashi
Journal: Kobe J Med Sci Date: 2017-05-09

5. Phase 1 study of the investigational Aurora A kinase inhibitor alisertib (MLN8237) in East Asian cancer patients: pharmacokinetics and recommended phase 2 dose.

Authors: Karthik Venkatakrishnan; Tae Min Kim; Chia-Chi Lin; Lim Soon Thye; Wee Joo Chng; Brigette Ma; Ming Huang Chen; Xiaofei Zhou; Hua Liu; Virginia Kelly; Won Seog Kim
Journal: Invest New Drugs Date: 2015-06-19 Impact factor: 3.850

6. Axitinib in metastatic renal cell carcinoma: results of a pharmacokinetic and pharmacodynamic analysis.

Authors: Brian I Rini; May Garrett; Bill Poland; Janice P Dutcher; Olivier Rixe; George Wilding; Walter M Stadler; Yazdi K Pithavala; Sinil Kim; Jamal Tarazi; Robert J Motzer
Journal: J Clin Pharmacol Date: 2013-03-28 Impact factor: 3.126

7. Pharmacokinetics and pharmacodynamics of single-dose oral tolvaptan in fasted and non-fasted states in healthy Caucasian and Japanese male subjects.

Authors: Susan E Shoaf; Seong Ryul Kim; Patricia Bricmont; Suresh Mallikaarjun
Journal: Eur J Clin Pharmacol Date: 2012-05-15 Impact factor: 2.953

8. Globalization of Alzheimer's disease clinical trials.

Authors: Jeffrey Cummings; Robert Reynders; Kate Zhong
Journal: Alzheimers Res Ther Date: 2011-08-17 Impact factor: 6.982

9. Absence of ethnic differences in the pharmacokinetics of moxifloxacin, simvastatin, and meloxicam among three East Asian populations and Caucasians.

Authors: Tomoko Hasunuma; Masahiro Tohkin; Nahoko Kaniwa; In-Jin Jang; Cui Yimin; Masaru Kaneko; Yoshiro Saito; Masahiro Takeuchi; Hiroshi Watanabe; Yasushi Yamazoe; Yoshiaki Uyama; Shinichi Kawai
Journal: Br J Clin Pharmacol Date: 2016-03-14 Impact factor: 4.335

10. Global population pharmacokinetics of the investigational Aurora A kinase inhibitor alisertib in cancer patients: rationale for lower dosage in Asia.

Authors: Xiaofei Zhou; Diane R Mould; Takatoshi Takubo; Emily Sheldon-Waniga; Dirk Huebner; Ashley Milton; Karthik Venkatakrishnan
Journal: Br J Clin Pharmacol Date: 2017-11-24 Impact factor: 4.335